Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor - Kubitza, D; Roth, A; Becka, M (Br J Clin Pharmacol, 2013)
et al.